Asep Medical Holdings Inc
SEPSF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $21 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $135 | $155 | $177 | $26 |
| Gross Profit | -$114 | -$155 | -$177 | -$26 |
| % Margin | -538% | – | – | – |
| R&D Expenses | $679 | $615 | $74 | $0 |
| G&A Expenses | $4,232 | $2,544 | $1,727 | $2 |
| SG&A Expenses | $4,232 | $2,544 | $1,727 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,697 | -$1 | -$26 | $0 |
| Operating Expenses | $7,608 | $5,443 | $1,978 | $2 |
| Operating Income | -$7,721 | -$5,443 | -$1,978 | -$28 |
| % Margin | -36,524.4% | – | – | – |
| Other Income/Exp. Net | -$1,709 | -$404 | -$290 | $0 |
| Pre-Tax Income | -$9,431 | -$5,846 | -$2,344 | -$28 |
| Tax Expense | $0 | -$89 | -$41 | $0 |
| Net Income | -$8,227 | -$4,525 | -$2,200 | -$28 |
| % Margin | -38,918.3% | – | – | – |
| EPS | -0.13 | -0.081 | -0.039 | -0.002 |
| % Growth | -61.5% | -105.4% | -1,963.2% | – |
| EPS Diluted | -0.13 | -0.081 | -0.039 | -0.002 |
| Weighted Avg Shares Out | 62,236 | 56,196 | 56,130 | 14,906 |
| Weighted Avg Shares Out Dil | 62,235 | 56,196 | 56,130 | 14,906 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $102 | $0 |
| Depreciation & Amortization | $1,294 | $1,282 | $177 | $28 |
| EBITDA | -$8,136 | -$3,331 | -$1,918 | $0 |
| % Margin | -38,486.2% | – | – | – |